• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiological update: Multistate outbreak of Salmonella Stanley infections (ECDC, December 12 2012)

Giuseppe

Emeritus
[Source: European Centre for Disease Prevention and Control (ECDC), full page: (LINK).]

Epidemiological update: Multistate outbreak of Salmonella Stanley infections

12 Dec 2012



Epidemiological and microbiological outbreak investigation at the European level

In July 2012, the European Centre for Disease Prevention and Control (ECDC) initiated a Europe-wide investigation on a Salmonella Stanley outbreak, together with the affected Member States, the European Food Safety Authority (EFSA) and the European Reference Laboratory for Salmonella (EURL Salmonella).

Cases were associated with strains showing an indistinguishable PFGE pattern not previously reported in Europe.

Between July and September 2012, ECDC encouraged European Union (EU) and European Economic Area (EEA) Member States to perform Xbal-PFGE typing on all S. Stanley human isolates.

The image profile of the outbreak strain was shared with all EU countries.

ECDC collected and analysed molecular typing data on S. Stanley from EU/EEA Member States to explore potential sources of infection within the food production chain in this multi-country outbreak.

Following the publication of the joint ECDC/EFSA rapid risk assessment on 21 September 2012, ECDC suggested to the EU/EEA Member States to perform PFGE typing only on a subset of isolates, and to report to ECDC on a monthly basis the number of non-travel associated S. Stanley cases, regardless of travel history within or outside the EU (possible outbreak related cases).

The objective of this update is to monitor the evolution of the outbreak.

Although the case definition for this monitoring purpose is broader than during the intensive phase of the outbreak (higher sensitivity), the epicurve is providing an indication of the development of the outbreak.

ECDC will provide a monthly update of the situation in the EU/EEA until the outbreak is considered over.

Ten EU Member States have had cases with PFGE results matching the PFGE outbreak profile.

These countries were asked to provide the number of non-travel related cases of S. Stanley identified per month between 1 August 2011 and 23 November 2012.

From 2007 to 2011, an average of nine cases of non-travel related S. Stanley infections were reported monthly to the European Surveillance System (TESSy) from the EU/EEA Member States.



Epidemiological update

Between 1 August 2011 and 23 November 2012, 611 cases of non-travel-related S. Stanley infections (probable and confirmed cases*) were identified in the EU:
  • Hungary (212),
  • Austria (186),
  • Germany (68),
  • Belgium (37),
  • United Kingdom (35),
  • Czech Republic (31),
  • Sweden (17),
  • Italy (14),
  • Slovakia (10), and
  • Greece (1) (Figure 1).

* See case definition at the end of the document

(?)

The number of cases reported is decreasing consecutively in September and October.

The number of cases identified in November is currently an underestimation, due to the delay in serotyping and reporting at national level.



Microbiological update

Comparative molecular epidemiological analyses of human, food, animal and environmental isolates? PFGE fingerprints performed by ECDC and the EURL Salmonella corroborate the available epidemiological evidence.

This provides additional evidence that strongly supports the conclusions of the ECDC/EFSA rapid risk assessment of 21 September 2012, in particular the implication of the turkey production chain as the probable main source of the outbreak.



Conclusions

The number of cases represented in this update provides an indication of the trend of the outbreak.

Despite the decrease in number of cases in September and October, the number of non-travel related cases reported these two months exceeds the background level.

Therefore the outbreak cannot yet be considered as over.

Additional cases are expected in November due to reporting delays.

ECDC will continue to monitor the situation.
The conclusions and recommendations of the joint ECDC/EFSA rapid risk assessment published on 21 September 2012 remain unchanged.

___________________________
* EU epidemic case definition for Salmonella Stanley multi-country outbreak


Confirmed case

A laboratory confirmed case of Salmonella Stanley with PFGE pattern matching the ?Belgium outbreak strain?

AND

Onset of symptoms after August 2011

AND

Without travel history outside the EU in 1?7 days prior the onset of symptoms



Probable case

A laboratory confirmed case of Salmonella Stanley, no PFGE available

AND

Onset of symptoms after August 2011

AND

Without travel history outside the EU in 1?7 days prior the onset of symptoms.



Exclusion criteria

If the Salmonella Stanley strain has a different PFGE profile it should be excluded.
-
------
 
Back
Top Bottom